chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 24 hours of Shot, I started to feel chills, also achy, slight heaviness in breathing, slightly runny nose. headache, and slight dizziness. Lasted approximately 1 week. And now I have tested positive to Covid as of 03/04/2021.
10 x 12 cm red area (R) arm at inj site. Area warm to touch. Tx'd with BENADRYL 50mg po q 6hrs and ADVIL PRN. Low grade fever over wknd.
Covid 19; Covid 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Feb2021 as dose 1, single (Lot number: Em9804) and on 01Oct2021 as dose 2, single (Lot number: Ff2587) at the age of 48 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "Covid 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient has not taken other medication in 2weeks. The patient has no Known allergies and no other medical history. The patient started paxlovid for treatment of COVID-19 on 29Jul2022.  No follow-up attempts are possible. No further information is expected.
have covid; have covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "have covid".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Arm was sore the day I received the vaccine. On 1/29 I becss as me sick and was very achey. symptoms improved but then On 2/6 my arm started to hurt again and is now red and inching at the injection site.
reached a low temperature of Negative 1.3 C and were out of range for 9 hours and 48 minutes with no adverse event; FLUZONE QIV NP PFS was administered to patient post temperature excursion with no reported adverse event; Initial information received on 16-Feb-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case is linked to cases 2023SA057733 and 2023SA057309.  This case involves adult patient of an unknown gender and reporter reported Influenza Quadrival A-B Vaccine [Fluzone Qiv] reached a low temperature of negative 1.3 c and were out of range for 9 hours and 48 minutes and was administered to patient post temperature excursion with no reported adverse event.  It was unknown if the patient had any medical history, medical treatment (s), concomitant disease or risk factor.  On an unknown date, the reporter reported Influenza Quadrival A-B Vaccine Suspension for injection (lot number: UT7683NA, UT7682JA; Expiry date: 30-06-2023) reached a low temperature of negative 1.3 c and were out of range for 9 hours and 48 minutes and was administered to patient post temperature excursion with no reported adverse event (product storage error) (latency: unknown)  (poor quality product administered) (latency: same day) (with an unknown strength, dose) via unknown route in unknown administration site for prophylactic vaccination (Immunisation).  It was unknown if the patient experienced any additional symptoms/events   It was unknown if there were lab data/results available.   Action taken: not applicable.   Outcome:  Unknown for both the reported events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  This situation is reported as a medication error due to temperature excursion that exceeded the stability data documented in the local labelling and additional supporting stability data.
I was fine for 27 hours. But for two hours I couldn't stand being in my body, then when ever I drink water or eat it feels like a spasm in my esophagus and its uncomfortable. I went to the first doc whos a GI and they never heard of it, I went to my doctor the other day and the same, no one heard of it. My regular doctor said to try Pepcid and I took one yesterday and it seemed to help.  As long as I'm not eating or drinking it's fine.
He broke out in a rash that is itching; This is a spontaneous report from a contactable consumer (patient's wife). A 62-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number unspecified, expiration date unspecified), dose 2 via an unspecified route of administration, administered in arm left on 25May2021 as 2nd dose, single for covid-19 immunization. Medical history included Blood pressure and AFib. Concomitant medication included losartan (50 mg) taken for blood pressure and tenecteplase (ELAXIM). On 26May2021, the patient broke out in a rash that was itching and reported as worsened. patient Just had normal meal, he never had been allergic to anything. The outcome of the event was not recovered.  Information about lot/batch number has been requested.
COULDN'T SLEEP FROM PAIN AND TINGLING IN ANKLES AND SHIN; INCREASED HEART RATE; ELEVATED BLOOD PRESSURE; ARM PAIN AT THE INJECTION SITE; BOTH LOWER ANKLE AND SHIN AREA FELT BURNING AND TINGLING; BOTH LOWER ANKLE AND SHIN AREA FELT PAINFUL/ PAIN IN ANKLE AND SHIN WAS GOING UP TOWARDS THE THIGH REGION; FEELING STICKY ON HANDS AND ARMS/ BODY FELT STICKY; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 18050301, expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 at Right Deltoid for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced feeling sticky on hands and arms/ body felt sticky. On 15-MAR-2021, the subject experienced both lower ankle and shin area felt burning and tingling. On 15-MAR-2021, the subject experienced both lower ankle and shin area felt painful/ pain in ankle and shin was going up towards the thigh region. On 19-MAR-2021, Laboratory data included: Blood pressure (NR: not provided) 148/75 mmHg. On 19-MAR-2021 02:00, the subject experienced couldn't sleep from pain and tingling in ankles and shin. On 19-MAR-2021 02:00, the subject experienced increased heart rate. On 19-MAR-2021 02:00, the subject experienced elevated blood pressure. On 19-MAR-2021 02:00, the subject experienced arm pain at the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from increased heart rate on 19-MAR-2021, was recovering from elevated blood pressure, and feeling sticky on hands and arms/ body felt sticky, had not recovered from both lower ankle and shin area felt painful/ pain in ankle and shin was going up towards the thigh region, couldn't sleep from pain and tingling in ankles and shin, and both lower ankle and shin area felt burning and tingling, and the outcome of arm pain at the injection site was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
9/17/09 approx 15:00 Pt presents with her mother to facility today for mmr and meningococcal vaccines. Immediately after the vaccines had been administered, pt became pale and fainted while sitting in the chair.  She came to quickly and then almost immediately fainted again. Again, she came to very quickly. After coming to each time, she immediately asked "what happened?".  Both times she fainted, her body "jerked momentarily" as she was passing out.  LPN was present the 2nd time the pt fainted. A wet, cool cloth was placed on her forehead and she c/o nausea though she never did vomit.  Vs were taken immediately: 1500: BP: 96/35, P: 54, O2Sats: 99%. She remained in the chair until I took her to a gurney to lie down via wheelchair at approx 1505. 1510: BP: 104/63, P: 55.  Explained to pt and her mother what causes fainting and reassured them that it is not uncommon to faint after getting injections or having blood draws.  They say this has never happened to her before. 1515: Pt lying down and states she's feeling better, but still with nausea. Color is much better. 1520: BP: 106/65, P: 57.  Pt is sitting up and drinking orange juice.  No c/o nausea at this time. 1525: BP: 117/74, P: 63. 1530: BP: 107/73, P: 50. 1535:  Pt feeling better and ready to leave.  No complaints at this time.  All questions answered.  Advised pt to tell medical personnel that she has a hx of fainting next time she needs shots or blood draw.  Pt agreed and verbalized understanding.  Pt left walking independently and with a steady gait. 1725:  I received a message to call patient's father.  When I called him back, he asked, "What caused my daughter to have a seizure today".  I explained she didn't have a seizure and he interrupted me with a raised voice and said "even a rocket scientist can tell someone's having a seizure if their arms are flailing, let alone a nurse".  (Father was not in the clinic today when the pt fainted).  I started to respond to father and he immediately asked to speak to my manager.  My manager is not in clinic today, so I transferred him to RN team lead.
itchy rash over entire body, with large swollen areas corresponding to rash sites on wrists and scalp. Rash appeared ~10.5 days after Moderna booster shot and has persisted for 3 days. Rash pattern consists of wide (>1cm) stripes of red, itchy raised skin on face & arms and large blocks of red, itchy raised skin on chest, back, and stomach. Some raised bumps within the red rash patches, but no blistering. Treatment has been management at home with two OTC allergy medications and topical antihistamine cream.
Moderna vaccine administered on left arm at 11 AM on 12/28/21. at 11:30 AM developed fever 102, myalgias, chills, headache, arthralgias, nausea, fatigue, dry cough, bilateral tender axillary lymphadenopathies.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Septra, reaction(s): "known allergies: Septra", notes: known allergies: Septra. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1st dose on Sep 2021, 2nd dose on 1 Oct 2021; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 53L2Z, expiry date 15th May 2022) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 17th Sep 2021.).   On 1st October 2021, the patient received the 2nd dose of Shingrix. On 1st October 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 08-NOV--2022 Reporters comment:  The patient received the first dose of shingrix on september 17th 2021 and the second dose of shingrix on October 1st 2021. The vaccine administration facility is the same as primary reporter The reporter consent to follow-up. Additional Supportive information: The patient received the first dose of shingrix on september 17th 2021 and the second dose of shingrix on October 1st 2021 which led to shortening of vaccinations schedule.
Information has been received from a medical assistant concerning a female with no pertinent medical history or drug allergies or drug reactions, who in November 2007, was vaccinated with ZOSTAVAX (Oka/Merck) intramuscular. Concomitant therapy included SYNTHROID and alendronate sodium. In November 2007, the patient was given ZOSTAVAX (Oka/Merck) intramuscular instead of subcutaneous. Subsequently the patient experienced soreness at injection site. The medical assistant stated that the physician mentioned that it was a nerve irritation. No laboratory tests were performed. The patient sought medical attention with an office visit. Additional information has been requested.
severe muscle pain and muscle weakness occurred  8 days after vaccinated,  improved with tylenol
Had full dose given... had pretty extreme reaction.  Fever, body aches, chills etc...swollen lymph node in left underarm swollen for 1-2 weeks and then the full body rash started and hasn't stopped since!  It feels like burning sporadically all over body.  Comes often and travels all over my body.  Sometimes looks like hives and now starting to bruise sometimes and unrelated to any incident too.  Still some body/joint aches too.  But the itchy body symptoms are unbearable for nearly a month!!!!!
Patient was vaccinated 9/7/2021, one week later she developed a rash of itchy bumps.  These bumps have increased in size over time.  Per the patient's report, she has been to the doctor and prescribed multiple courses of creams, and oral steroids but nothing has given her lasting relief. When the patient contacted me October of 2022, she reports that the bumps have now turned to sores.
Unable to move arm by 5pm same day of vaccine drowsiness; unable to undress-had to have help from neighbor; vomiting/diarrhea x2days; throbbing arm x4 days; upper arm/armpit painful; still uncomfortable as of 7/17/18.
Information has been received from a consumer concerning her 7 year old son who on unspecified date was vaccinated with MMR II. The patient developed autism after having been given MMR II. The patient had sought unspecified medical attention. No further information is available. Upon internal review, the patient's autism was determined to be an other important medical event. Additional information is expected.
Approximately a week after shot 1 the arm that the shot was given in started to turn red.  It appeared to be a rash.  The rash increased in size each day there after.  There was no itching or pain involved with the rash.  By about the 10th day out my lymph nodes (same arm) in my arm pit swelled.   At this point the rash extended from my shoulder to my elbow and went around my arm.   I thought I had an infection so I called my doctor and they instructed me to go to Well Now Urgent Care.  I believe I saw a Physician Assistant.  She had said that they have seen some rashes but not as big/extensive as mine.  She asked if she could take pictures to show to their Infectious Disease Doctor.  I gave her permission.  She also had another colleague come in and exam my arm and lymph nodes.  They were unsure what it was so they prescribed me 500mg Cephalexin once a day.  I took the medication and that seemed to clear the rash and swelling of the lymph nodes.  I did not require any other medical attention after that.  I received my 2nd dose on February 9th and I did not experience any issues.
p/recv vax pt exp jerking arms/legs, not responding to me, blue lips & legs, gagging or chocking, like a mild seizure
Pt was given varicella vaccine on 02/11/1997. Was diagnosed with Varicella zoster 12/24/04.
The patient's age (17 years) was noted at data entry following the Point of Dispensing Clinic.  The patient presented with family to the POD and all are members of a local fire department. No adverse reactions were noted; the patient has not contacted Department of Health to report any adverse reactions. The patient was contacted to aid in the completion of this report but was not able to be reached by phone.
Patient reports pain to his left deltoid radiating down his arm, some pain to scapula ever since the flu vaccine was given on 11/20/17.
Became having heart palpitations and elevated heart rate both resting and on  exertion. Would increase in severity on exertion.   On 9/23/21 began feeling chest pain that was a heavy feeling on my left side with extreme tightness. I tried going to primary care but was referred to ER. Went to ER approx 5:30pm that day. ER at EMMC ran labs including a d dimer, CMP, Troponin, CBC, thyroid, electrolytes, and urinalysis. No abnormal findings. They also did a chest x ray and EKG which also came back normal. Covid test also negative. Upon asking, they denied filing a VAERS and said I was primary cares responsibility to determine if they wanted to file one. They said to possibly follow up with primary care to possibly get a Holter monitor or possible echocardiogram for re-evaluation.
I, am reporting this VAER on behalf of my brother who is currently incarcerated in a state correctional facility in PA. During a phone call a few days following his vaccine, he told me that his continues to experience shoulder pain and issues with range of motion following administration of the J&J COVID vaccine.  When he first informed me, I asked him if the discomfort he was feeling was expected  pain and discomfort at the injection site, to which he responded no. He reports that a couple days following administration upon stretching when waking he experienced shooting  left upper arm/shoulder pain and reduced ROM the arm in which he received the vaccine. I am reporting this adverse event as he is still having this issue.
pt recv vax 12JAN99 & 2 days later lt leg red & swollen above knee area;hot to touch;
This spontaneous report was received from a currently 61 year old female consumer reporting on herself. The patient had no pertinent medical history, drug reactions/allergies. On an unknown date the patient was vaccinated with ZOSTAVAX (lot number, route and dose were not specified) injection. No concomitant medications were reported. Consumer reported she experienced a "rash" that "burned and itched" after receiving the ZOSTAVAX. Consumer also stated that she did visit the practicing physician and she was diagnosed with "poison ivy". Consumer stated she was not certain that the rash was from ZOSTAVAX. Consumer was almost convinced that this rash was "poison ivy". Patient received BENADRYL (manufacturer unspecified) (1 pill every 4 hours) as needed as treatment for poison ivy. No lab diagnostics studies were performed. The outcome of poison ivy was not reported. The relationship between ZOSTAVAX and the events was not reported. Additional information has been requested.
Information has been provided from an anonymous female consumer who in approximately July 1998, approximately two and a half years ago, was vaccinated with her third dose of Pneumococcal vaccine 23 Polyvalent. The patient stated that the vaccination is now "attacking" and "degenerating" all of the elastic fibers in her body. The caller stated that she already reported this to someone else, But would not say to whom. The patient sought unspecified medical attention. Upon internal review the patient's experience was determined to be an other important medical event.
Not feeling good; Headache; Itchy arm; It was all red at injection site/an eight-inch red area at injection site.; Left arm was v sore; Swelled arm; Having difficulty walking due to muscle fatigue; She can barely lift it; Muscle fatigue; Slept all day; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Having difficulty walking due to muscle fatigue), LIMB DISCOMFORT (She can barely lift it), MUSCLE FATIGUE (Muscle fatigue), SOMNOLENCE (Slept all day) and MALAISE (Not feeling good) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced GAIT DISTURBANCE (Having difficulty walking due to muscle fatigue), LIMB DISCOMFORT (She can barely lift it), MUSCLE FATIGUE (Muscle fatigue), SOMNOLENCE (Slept all day), VACCINATION SITE SWELLING (Swelled arm) and VACCINATION SITE PAIN (Left arm was v sore). On 25-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE ERYTHEMA (It was all red at injection site/an eight-inch red area at injection site.). On an unknown date, the patient experienced MALAISE (Not feeling good) and HEADACHE (Headache). At the time of the report, GAIT DISTURBANCE (Having difficulty walking due to muscle fatigue), LIMB DISCOMFORT (She can barely lift it), MUSCLE FATIGUE (Muscle fatigue), SOMNOLENCE (Slept all day), VACCINATION SITE SWELLING (Swelled arm) and VACCINATION SITE PAIN (Left arm was v sore) had resolved, MALAISE (Not feeling good) and HEADACHE (Headache) outcome was unknown and VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE ERYTHEMA (It was all red at injection site/an eight-inch red area at injection site.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient post receiving their first dose of vaccine 1st shot and on the next day their left arm was very sore and could barely lift it. The patient reported that they slept whole day, had muscle fatigue which lasted for a week due to which the patient was having difficulty in walking. The patient also experienced swelled arm which went away and on day 11, the patient had itchy arm and it was all red at injection site and was still not going away.  On 24-Jun-2021 the patient reported that the patient had an eight-inch red area at the injection site.  No Concomitant product use was reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow-up was received on 22-Apr-2021 and contains non significant information. On 24-Jun-2021: Follow-up was received on 24-Jun-2021. Updated the event verbatim of the event Vaccination site erythema.
Pt recvd 3 doses of Engerix-B; Titer test indicated did not respond;
Client passed out-Syncopal episode. Going to Hospital. BS-96, BP 80/40, HR 58, O2 97%.